for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd

600332.SS

Latest Trade

37.68CNY

Change

0.74(+2.00%)

Volume

33,086,410

Today's Range

36.19

 - 

38.15

52 Week Range

32.06

 - 

45.88

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Guangzhou Baiyunshan Pharma's 9-Month Net Profit Down 8.1% Y/Y

Oct 28 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings co Ltd <600332.SS>0874.HK::SAYS 9-MONTH NET PROFIT DOWN 8.1% Y/Y.

Guangzhou Baiyunshan Plans Spin Off Guangzhou Unit For Hong Kong Listing

Sept 10 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS IT PLANS TO SPIN OFF ITS GUANGZHOU UNIT FOR LISTING IN HONG KONG STOCK EXCHANGE.SAYS UNIT PLANS TO ISSUE ASSET-BACKED SECURITIES WORTH UP TO 3.0 BILLION YUAN ($422.27 million).

Guangzhou Baiyunshan Pharmaceutical's H1 Net Profit Down 2.7% Y/Y

Aug 22 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK ::SAYS H1 NET PROFIT DOWN 2.7% Y/Y.

Lock-Up Period For Guangzhou Baiyunshan's 334.7 Million A-Shares To End

Aug 12 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS LOCK-UP PERIOD FOR 334.7 MILLION A-SHARES TO END, TRADING TO START FROM AUG 19.

Guangzhou Baiyunshan Pharmaceutical Says Chen Mao Resigned As Vice Chairperson

May 31 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::CHEN MAO RESIGNED AS AN EXECUTIVE DIRECTOR AND VICE CHAIRPERSON OF CO.

Guangzhou Baiyunshan Pharmaceutical's Q1 Net Profit Up 55.4 Percent Y/Y

April 28 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 0874.HK<600332.SS>::SAYS Q1 NET PROFIT UP 55.4 PERCENT Y/Y.

Guangzhou Baiyunshan Pharma's 2018 Net Profit Up 66.9 Percent Y/Y At 3.4 Billion Yuan

March 17 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 0874.HK<600332.SS>::SAYS 2018 NET PROFIT UP 66.9 PERCENT Y/Y AT 3.4 BILLION YUAN ($506.49 million).

Guangzhou Baiyunshan Pharmaceutical Sees 2018 Net Profit Up 57.6-89.2 Percent Y/Y

Jan 30 (Reuters) - Guangzhou Baiyunshan Pharmaceutical <600332.SS>0874.HK::SAYS IT SEES 2018 NET PROFIT UP 57.6-89.2 PERCENT Y/Y FROM 2.06 BILLION YUAN ($306.74 million) YEAR EARLIER.

Guangzhou Baiyunshan Pharmaceutical To Acquire Wanglaoji Series Trademarks

Dec 27 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::CO TO ACQUIRE WANGLAOJI SERIES TRADEMARKS FOR RMB1.39 BILLION FROM CONTROLLING SHAREHOLDER.

Guangzhou Baiyunshan Pharmaceutical's 9-Month Net Profit Up 131.5 Percent Y/Y

Oct 29 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS 9-MONTH NET PROFIT UP 131.5 PERCENT Y/Y.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up